EX-12.A 6 a2087960zex-12_a.htm EXHIBIT 12(A)
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 12(a)

Science Applications International Corporation
Ratio of Earnings to Fixed Charges

(Amounts in thousands)

		Year Ended January 31,
		Year Ended January 31,														Three Months ended April 30, 2002
		1998			1999		2000			2001			2002			Three Months ended April 30, 2002
Income before income taxes		$	158,493		$	287,995	$	1,061,385	(1)	$	3,278,593	(2)	$	27,052	(3)	$	50,315	(4)
Add:
	Minority interest in consolidated subsidiaries with fixed charges		10,608			17,842		44,200			12,616			16,849			3,684
	Equity investee distributions		161			95		345			364			1,356			5,100
	Losses in equity investments					4,185		6,123
	Amortization of capitalized interest																7
	Interest on indebtedness		11,682			33,813		27,274			19,615			19,256			4,548
	Portion of rent expense representative of the interest factor		30,004			37,773		47,732			47,106			49,805			10,318
Less:
	Capitalized interest													(1,157	)
	Undistributed income in equity investments		(1,326	)							(6,047	)		(2,691	)		(1,030	)

Income before income taxes, adjusted		$	209,622		$	381,703	$	1,187,059		$	3,352,247		$	110,470		$	72,942

Fixed charges:
	Interest on indebtedness	$	11,682		$	33,813	$	27,274		$	19,615		$	19,256		$	4,548
	Portion of rent expense representative of the interest factor		30,004			37,773		47,732			47,106			49,805			10,318

Total fixed charges		$	41,686		$	71,586	$	75,006		$	66,721		$	69,061		$	14,866

Ratio of earnings to fixed charges			5.0			5.3		15.8	(1)		50.2	(2)		1.6	(3)		4.9	(4)

(1): Includes gain on sale of subsidiary stock of $698,374,000 and net gain of $2,498,000 on marketable securities and other investments. Excluding such gains, the ratio of earnings to fixed charges would have been 6.5.
(2): Includes net gain on marketable securities and other investments, including impairment losses, of $2,656,433,000. Excluding such net gain, the ratio of earnings to fixed charges would have been 10.4.
(3): Includes net loss on marketable securities and other investments, including impairment losses, of $455,752,000. Excluding such net loss, the ratio of earnings to fixed charges would have been 8.2.
(4): Includes net loss on marketable securities and other investments, including impairment losses, of $60,483,000. Excluding such net loss, the ratio of earnings to fixed charges would have been 9.0.